Salerno Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SALERNO PHARMS, and what generic alternatives to SALERNO PHARMS drugs are available?
SALERNO PHARMS has one approved drug.
There are two US patents protecting SALERNO PHARMS drugs.
There are eight patent family members on SALERNO PHARMS drugs in twelve countries and five supplementary protection certificates in five countries.
Drugs and US Patents for Salerno Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-001 | Apr 21, 2016 | RX | Yes | No | 10,300,041 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-002 | Apr 21, 2016 | RX | Yes | Yes | 9,597,289 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-001 | Apr 21, 2016 | RX | Yes | No | 9,597,289 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-002 | Apr 21, 2016 | RX | Yes | Yes | 10,300,041 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Salerno Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2009534459 | ⤷ Sign Up |
Portugal | 2018153 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2007125339 | ⤷ Sign Up |
Spain | 2385752 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Salerno Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0720599 | 05C0040 | France | ⤷ Sign Up | PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402 |
0720599 | 26/2005 | Austria | ⤷ Sign Up | PRODUCT NAME: EZETIMIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON KOMBINIERT MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 1-25673 - 1-25676 20041228; FIRST REGISTRATION: DE 58874.00.00 - 58874.03.00; 58878.00.00 - 20040402 |
0720599 | SPC/GB05/010 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: EZETIMIBE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN COMBINATION WITH SIMVASTATIN; REGISTERED: DE 58874.00.00 20040402; DE 58874.01.00 20040402; DE 58874.02.00 20040402; DE 58874.03.00 20040402; DE 58878.00.00 20040402; DE 58878.01.00 20040402; DE 58878.02.00 20040402; DE 58878.03.00 20040402; DE 58866.00.00 20040402; DE 58866.01.00 20040402; DE 58866.02.00 20040402; DE 58866.03.00 20040402; DE 58870.00.00 20040402; DE 58870.01.00 20040402; DE 58870.02.00 20040402; DE 58870.03.00 20040402; UK PL 19945/0003 20041118; UK PL 19945/0004 20041118; UK PL 19945/0005 20041118; UK PL 19945/0006 20041118; UK PL 19945/0007 20041118; UK PL 19945/0008 20041118; UK PL 19945/0009 200411 |
0720599 | 122004000026 | Germany | ⤷ Sign Up | PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 58866.00.00 58866.01.00 58866.02.00 58866.03.00 58870.00.00 58870.01.00 58870.02.00 58870.03.00 58874.00.00 58874.01.00 58874.02.00 58874.03.00 58878.00.00 58878.01.00 58878.02.00 58878.03.00 20040402 FIRST REGISTRATION: DE 58866.00.00 - 58866.03.00 58870.00.00 - 58870.03.00 58874.00.00 - 58874.03.00 58878.00.00 - 58878.03.00 20040402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.